Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

What Nutrition Labels Really Tell Us — And How To Read One Like An Expert

Chemists, nutritionists, and food scientists help us make sense of the back of the box, starting with a Nutri-grain bar — and other common food products.

Inverse

Regeneron: Is It the Perfect Biotech Stock for Value and Growth?

Regeneron is trading at historically low valuations as its Dupixent blockbuster drug could get a 30% increase in TAM if the FDA approves its use in COPD.

MarketBeat

Abortion pill manufacturer asks to join suit that could rewrite US abortion access

GenBioPro seeks to defend access to mifepristone in suit brought by attorneys general of Idaho, Missouri and Kansas

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Pixel Watch 3 gets FDA approval for Loss of Pulse Detection in US

Coming in March 2025, Loss of Pulse Detection joins Fall Detection and Car Crash Detection as a potential life-saving Pixel Watch 3 tool.

Android Central

Wall Street’s Most Wanted: 2 Highly Shorted Stocks Right Now

See why these two high-flying stocks are among the most shorted in the market, plus counterarguments amid bearish gripes.

MarketBeat

Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?

Viking Therapeutics stock jumped on rumors of a potential acquirer looking to add a GLP-1 treatment to their portfolio and VK2735 appears to rival Zepbound.

MarketBeat

Trump tasks son’s hunting pal with keeping the US food supply safe

Kyle Diamantas, Florida attorney with ties to Donald Trump Jr, will oversee about 80% of US food supply

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Hims & Hers Stock Is Plunging on Weight-Loss Drug Halt. Should You Buy the Dip?

Concerns over near-term profit margins and the loss of potential revenue from compounded semaglutide weigh on Hims & Hers stock.

Barchart

The Latest: Musk renews threat to fire federal workers despite pushback from various agencies

Elon Musk is vowing yet again to fire any federal workers who don’t respond to an email asking them to list five things they accomplished last week

The Independent UK

FDA Reinstates Fired Staff After Industry Pushback

FDA rescinds mass firings of probationary staffers following industry lobbying efforts, raising concerns about regulatory obligations amidst budget challenges.

Top News

Dozens sickened and 12 dead in Listeria outbreak linked to frozen shakes

An ongoing Listeria outbreak has mostly affected people living in long-term care facilities and people who were already hospitalized prior to becoming sick from the infection.

LiveScience

Why IBD 50's Top Seed, Hims & Hers, Just Crashed On Its Upbeat Earnings

Hims stock plunged Tuesday after the compounding pharmacy issued a bullish outlook that still includes knockoff versions of semaglutide.

Investors Business Daily

The Latest: Federal workers face mass confusion as Musk’s deadline to list accomplishments looms

Confusion and chaos loom as hundreds of thousands of federal employees begin their workweek Monday facing a deadline from President Donald Trump’s cost-cutting chief, Elon Musk, to explain their recent accomplishments or risk losing their jobs

The Independent UK

FDA moves to rehire medical device staffers fired only days earlier

The Food and Drug Administration is reinstating some of the hundreds of staffers it fired last week

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Scientists reviewing Musk’s Neuralink are fired – then rehired – from FDA following flurry of DOGE cuts

Around 300 FDA staffers have been asked to return to work after Musk’s DOGE axed thousands of jobs from the Department of Health and Human Services

Barchart

2 ‘Strong Buy’ Stocks Under $10 Set to Surge as Much as 331%

These biotech companies are poised for significant long-term growth. However, there are risks.

Android Central

I'm almost embarrassed how much I dig this gimmicky smart ring

I thought the Casio ring watch was too goofy to be real; now I'm hooked on wearing it and wondering if I want more smart ring "gimmicks"

The Independent UK

Shakes sold to nursing homes across the U.S. recalled after listeria outbreak linked to 12 deaths

Investigators have been unable to trace the source of the outbreak

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

Gilead Sciences: 4 Reasons This Stock Has Much More To Rise

Gilead Pharmaceuticals is back to highs not seen in a decade as its HIV treatment franchise surges and awaits its 100% effective HIV prevention drug in summer

The Independent UK

Hundreds in DOGE purge had jobs not paid by taxpayers - lowering the amount of savings America sees by cuts

The recent firings at the Food and Drug Administration and the Federal Deposit Insurance Corporation ‘do nothing to reduce the federal budget’

Reason

The Sunny Side of Donald Trump's Power Grabs

The president is positioning himself to have much greater control over a smaller, enfeebled federal bureaucracy.

StockNews.com

3 Gene Therapy Stocks With Game-Changing Potential

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, investing in gene therapy stocks like Pfizer (PFE), Sanofi (SNY), and Novartis AG (NVS) could be beneficial. Read on….

The Independent UK

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity treatments continue to improve

LiveScience

Deadly motor-neuron disease treated in the womb in world 1st

An infant with a fatal genetic disease has survived past the age of 2 with no signs of the condition, thanks to treatment started in the womb.

Investors Business Daily

Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage

HIMS stock fell after the FDA said the shortages in Novo Nordisk's weight-loss drug has been resolved.

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.